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Suboxone Treatment in 
Caribou, ME
Evaluating Barriers and Engaging With
Mid-Level Providers
Michael Ialeggio.  University of Vermont Medical School.  Nov 2016.
The Problem
“Drug overdose deaths in Maine now averaging 1 a Day”
Portland Press Herald, 11/14/16
“Drug overdose deaths in Maine through the first nine months of 2016 have 
surpassed the total for all of 2015 as the opioid epidemic continues to worsen.”
This summer, the Comprehensive 
Addiction and Recovery Act (CARA) 
was passed in Congress and signed 
into law 
There is increasing 
recognition that Opiate 
Dependence is a chronic and 
relapsing condition*.
Improving access to 
Medication Assisted 
Treatment is a key feature of 
the law.  
Vogel, M, Dürsteler KM, Walter M, Herdener M, Nordt C.  “Rethinking retention in treatment of 
opioid dependence-The eye of the beholder.”  Int J Drug Policy. 2016 Oct 24;39:109-113. 
In Caribou…
The Aroostook Mental Health Center (AMHC) Medication Assisted 
Recovery (MAR) Program was started in partnership with local provider 
group, “Pines Health Services”, after a town hall meeting in 2004 was 
attended by over 1000 concerned townspeople.
Initially, 6 providers were trained.  At its peak, the AMHC MAR program 
served 120 patients.  The number of providers and the number of 
patients served has dwindled in the past several years.
According to Data gathered 
between 2009 and 2011, 
Aroostook County actually 
has a slightly lower burden of 
Opiate use than other areas 
of Maine.
Peak Current
6 providers 2 providers
Open 2 days per week Open 3.5 days per month




Opiate Poisoning                      








Opiates In Aroostook County, ME
2015 Shared Community Health Needs Assessment: Aroostook County
Community Perspective
“At that time (early in the program), we had more patients because there were a number of providers 
working together.  The ER docs dropped out first, primarily because of scheduling…  I find it interesting when 
I do it a couple times a month.  Any more than that I think I would get frustrated.”
Local prescriber
“I have seen people who were total train-wrecks, who now have a job and can buy a house…  I understand 
why (other providers) don’t want to treat.  I have a 3000 patient panel and my Suboxone patients give me 
more trouble than all of the rest combined…  (But) it is a community thing, the community’s responsibility.”
Local Prescriber
“I knew it was going to burn me out…We need to bring in some new blood.”
Former Local Prescriber
“We could definitely use an additional 5 or 6 provider hours.”
“I need more providers!”
Staff, AMHC
Methodology/Project
• Conducted interviews with Current, Past and ‘Never’ providing 
doctors to identify motivations and barriers to prescribing 
Opiate Replacement Therapy
• Researched details of implementation timeline for CARA, and 
implications for mid-level providers
• Designed and Printed Pamphlets
• Initiated 5 minute ‘focused interventions’ with local NPs and 
PAs to talk about challenges and rewards of becoming a 




• ‘Focused Interventions’ with 5 Mid Level Providers
• Additional pamphlets distributed at Van Buren, Caribou, and Presque Isle 
Offices
• Providers shared following concerns:
• Unsure about Efficacy of MAR program
• Difficult Patient Population
• Training Requirements are 3x higher (24hrs vs 8 hrs)
• Continuity of Care: pts see different provider each visit (inconsistency/splitting)
Effectiveness and Limitations
• Intent of project was to start conversations about difficult subject, increase 
awareness, and promote interest in becoming a MAR provider among PAs 
and NPs. No means of evaluation built into project.  
• Most providers were aware of new law and had some knowledge of 
program at AMHC.  All were willing to discuss concerns, and hear about 
experiences of past and current providers.  
• There is no set date for when guidelines for mid-level providers will be 
finalized (stipulated to be within 18 months of July 2016)
Lessons Learned:
Future Interventions & Projects
• It will be important to follow up as CARA is implemented!  (See Pamphlet)
• Work with AMHC to develop more “Outcomes” data
• Potential providers are looking for evidence of efficacy
• Work to address current and potential provider frustrations
• More providers, small patient panels?
• How to address issues of continuity/inconsistency/splitting with multiple 
part time providers
• One Provider per Patient model?
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